ID   F263_HUMAN              Reviewed;         520 AA.
AC   Q16875; B7Z955; O43622; O75902; Q5VX15; Q5VX18; Q5VX19;
DT   15-JUL-1998, integrated into UniProtKB/Swiss-Prot.
DT   01-NOV-1996, sequence version 1.
DT   10-MAY-2017, entry version 178.
DE   RecName: Full=6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase 3;
DE            Short=6PF-2-K/Fru-2,6-P2ase 3;
DE            Short=PFK/FBPase 3;
DE   AltName: Full=6PF-2-K/Fru-2,6-P2ase brain/placenta-type isozyme;
DE   AltName: Full=Renal carcinoma antigen NY-REN-56;
DE   AltName: Full=iPFK-2;
DE   Includes:
DE     RecName: Full=6-phosphofructo-2-kinase;
DE              EC=2.7.1.105;
DE   Includes:
DE     RecName: Full=Fructose-2,6-bisphosphatase;
DE              EC=3.1.3.46;
GN   Name=PFKFB3;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1).
RC   TISSUE=Placenta;
RX   PubMed=8830046; DOI=10.1093/oxfordjournals.jbchem.a021270;
RA   Sakai A., Kato M., Fukasawa M., Ishiguro M., Furuya E., Sakakibara R.;
RT   "Cloning of cDNA encoding for a novel isozyme of fructose 6-phosphate,
RT   2-kinase/fructose 2,6-bisphosphatase from human placenta.";
RL   J. Biochem. 119:506-511(1996).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1).
RX   PubMed=9146922; DOI=10.1023/A:1018482511456;
RA   Nicholl J., Hamilton J.A., Sutherland G.R., Sutherland R.L.,
RA   Watts C.K.;
RT   "The third human isoform of 6-phosphofructo-2-kinase/fructose-2,6-
RT   bisphosphatase (PFKFB3) map position 10p14-p15.";
RL   Chromosome Res. 5:150-150(1997).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1).
RC   TISSUE=Brain;
RX   PubMed=10072580;
RA   Manzano A., Rosa J.L., Ventura F., Perez J.X., Nadal M., Estivill X.,
RA   Ambrosio S., Gil J., Bartrons R.;
RT   "Molecular cloning, expression, and chromosomal localization of a
RT   ubiquitously expressed human 6-phosphofructo-2-kinase/ fructose-2, 6-
RT   bisphosphatase gene (PFKFB3).";
RL   Cytogenet. Cell Genet. 83:214-217(1998).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA] (ISOFORM 1).
RC   TISSUE=Brain;
RA   El-Maghrabi M.R.;
RT   "Human brain 6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase.";
RL   Submitted (JAN-1998) to the EMBL/GenBank/DDBJ databases.
RN   [5]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 2).
RC   TISSUE=Skeletal muscle;
RX   PubMed=10077634; DOI=10.1073/pnas.96.6.3047;
RA   Chesney J., Mitchell R.A., Benigni F., Bacher M., Spiegel L.,
RA   Al-Abed Y., Han J.H., Metz C., Bucala R.;
RT   "An inducible gene product for 6-phosphofructo-2-kinase with an AU-
RT   rich instability element: role in tumor cell glycolysis and the
RT   Warburg effect.";
RL   Proc. Natl. Acad. Sci. U.S.A. 96:3047-3052(1999).
RN   [6]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORMS 1 AND 4).
RC   TISSUE=Trachea;
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A.,
RA   Sudo H., Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M.,
RA   Takahashi M., Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y.,
RA   Abe K., Kamihara K., Katsuta N., Sato K., Tanikawa M., Yamazaki M.,
RA   Ninomiya K., Ishibashi T., Yamashita H., Murakawa K., Fujimori K.,
RA   Tanai H., Kimata M., Watanabe M., Hiraoka S., Chiba Y., Ishida S.,
RA   Ono Y., Takiguchi S., Watanabe S., Yosida M., Hotuta T., Kusano J.,
RA   Kanehori K., Takahashi-Fujii A., Hara H., Tanase T.-O., Nomura Y.,
RA   Togiya S., Komai F., Hara R., Takeuchi K., Arita M., Imose N.,
RA   Musashino K., Yuuki H., Oshima A., Sasaki N., Aotsuka S.,
RA   Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y.,
RA   Fujimori Y., Komiyama M., Tashiro H., Tanigami A., Fujiwara T.,
RA   Ono T., Yamada K., Fujii Y., Ozaki K., Hirao M., Ohmori Y.,
RA   Kawabata A., Hikiji T., Kobatake N., Inagaki H., Ikema Y., Okamoto S.,
RA   Okitani R., Kawakami T., Noguchi S., Itoh T., Shigeta K., Senba T.,
RA   Matsumura K., Nakajima Y., Mizuno T., Morinaga M., Sasaki M.,
RA   Togashi T., Oyama M., Hata H., Watanabe M., Komatsu T.,
RA   Mizushima-Sugano J., Satoh T., Shirai Y., Takahashi Y., Nakagawa K.,
RA   Okumura K., Nagase T., Nomura N., Kikuchi H., Masuho Y., Yamashita R.,
RA   Nakai K., Yada T., Nakamura Y., Ohara O., Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [7]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=15164054; DOI=10.1038/nature02462;
RA   Deloukas P., Earthrowl M.E., Grafham D.V., Rubenfield M., French L.,
RA   Steward C.A., Sims S.K., Jones M.C., Searle S., Scott C., Howe K.,
RA   Hunt S.E., Andrews T.D., Gilbert J.G.R., Swarbreck D., Ashurst J.L.,
RA   Taylor A., Battles J., Bird C.P., Ainscough R., Almeida J.P.,
RA   Ashwell R.I.S., Ambrose K.D., Babbage A.K., Bagguley C.L., Bailey J.,
RA   Banerjee R., Bates K., Beasley H., Bray-Allen S., Brown A.J.,
RA   Brown J.Y., Burford D.C., Burrill W., Burton J., Cahill P., Camire D.,
RA   Carter N.P., Chapman J.C., Clark S.Y., Clarke G., Clee C.M., Clegg S.,
RA   Corby N., Coulson A., Dhami P., Dutta I., Dunn M., Faulkner L.,
RA   Frankish A., Frankland J.A., Garner P., Garnett J., Gribble S.,
RA   Griffiths C., Grocock R., Gustafson E., Hammond S., Harley J.L.,
RA   Hart E., Heath P.D., Ho T.P., Hopkins B., Horne J., Howden P.J.,
RA   Huckle E., Hynds C., Johnson C., Johnson D., Kana A., Kay M.,
RA   Kimberley A.M., Kershaw J.K., Kokkinaki M., Laird G.K., Lawlor S.,
RA   Lee H.M., Leongamornlert D.A., Laird G., Lloyd C., Lloyd D.M.,
RA   Loveland J., Lovell J., McLaren S., McLay K.E., McMurray A.,
RA   Mashreghi-Mohammadi M., Matthews L., Milne S., Nickerson T.,
RA   Nguyen M., Overton-Larty E., Palmer S.A., Pearce A.V., Peck A.I.,
RA   Pelan S., Phillimore B., Porter K., Rice C.M., Rogosin A., Ross M.T.,
RA   Sarafidou T., Sehra H.K., Shownkeen R., Skuce C.D., Smith M.,
RA   Standring L., Sycamore N., Tester J., Thorpe A., Torcasso W.,
RA   Tracey A., Tromans A., Tsolas J., Wall M., Walsh J., Wang H.,
RA   Weinstock K., West A.P., Willey D.L., Whitehead S.L., Wilming L.,
RA   Wray P.W., Young L., Chen Y., Lovering R.C., Moschonas N.K.,
RA   Siebert R., Fechtel K., Bentley D., Durbin R.M., Hubbard T.,
RA   Doucette-Stamm L., Beck S., Smith D.R., Rogers J.;
RT   "The DNA sequence and comparative analysis of human chromosome 10.";
RL   Nature 429:375-381(2004).
RN   [8]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RA   Mural R.J., Istrail S., Sutton G., Florea L., Halpern A.L.,
RA   Mobarry C.M., Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R.,
RA   Flanigan M.J., Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V.,
RA   Hannenhalli S., Turner R., Yooseph S., Lu F., Nusskern D.R.,
RA   Shue B.C., Zheng X.H., Zhong F., Delcher A.L., Huson D.H.,
RA   Kravitz S.A., Mouchard L., Reinert K., Remington K.A., Clark A.G.,
RA   Waterman M.S., Eichler E.E., Adams M.D., Hunkapiller M.W., Myers E.W.,
RA   Venter J.C.;
RL   Submitted (SEP-2005) to the EMBL/GenBank/DDBJ databases.
RN   [9]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1).
RC   TISSUE=Testis;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [10]
RP   IDENTIFICATION AS A RENAL CANCER ANTIGEN.
RC   TISSUE=Renal cell carcinoma;
RX   PubMed=10508479;
RX   DOI=10.1002/(SICI)1097-0215(19991112)83:4<456::AID-IJC4>3.0.CO;2-5;
RA   Scanlan M.J., Gordan J.D., Williamson B., Stockert E., Bander N.H.,
RA   Jongeneel C.V., Gure A.O., Jaeger D., Jaeger E., Knuth A., Chen Y.-T.,
RA   Old L.J.;
RT   "Antigens recognized by autologous antibody in patients with renal-
RT   cell carcinoma.";
RL   Int. J. Cancer 83:456-464(1999).
RN   [11]
RP   PHOSPHORYLATION AT SER-461.
RX   PubMed=12065600; DOI=10.1074/jbc.M205213200;
RA   Marsin A.S., Bouzin C., Bertrand L., Hue L.;
RT   "The stimulation of glycolysis by hypoxia in activated monocytes is
RT   mediated by AMP-activated protein kinase and inducible 6-
RT   phosphofructo-2-kinase.";
RL   J. Biol. Chem. 277:30778-30783(2002).
RN   [12]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-461; THR-463 AND
RP   SER-467, AND IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE
RP   ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=18669648; DOI=10.1073/pnas.0805139105;
RA   Dephoure N., Zhou C., Villen J., Beausoleil S.A., Bakalarski C.E.,
RA   Elledge S.J., Gygi S.P.;
RT   "A quantitative atlas of mitotic phosphorylation.";
RL   Proc. Natl. Acad. Sci. U.S.A. 105:10762-10767(2008).
RN   [13]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-461 AND SER-467, AND
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Leukemic T-cell;
RX   PubMed=19690332; DOI=10.1126/scisignal.2000007;
RA   Mayya V., Lundgren D.H., Hwang S.-I., Rezaul K., Wu L., Eng J.K.,
RA   Rodionov V., Han D.K.;
RT   "Quantitative phosphoproteomic analysis of T cell receptor signaling
RT   reveals system-wide modulation of protein-protein interactions.";
RL   Sci. Signal. 2:RA46-RA46(2009).
RN   [14]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-461 AND SER-467, AND
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=20068231; DOI=10.1126/scisignal.2000475;
RA   Olsen J.V., Vermeulen M., Santamaria A., Kumar C., Miller M.L.,
RA   Jensen L.J., Gnad F., Cox J., Jensen T.S., Nigg E.A., Brunak S.,
RA   Mann M.;
RT   "Quantitative phosphoproteomics reveals widespread full
RT   phosphorylation site occupancy during mitosis.";
RL   Sci. Signal. 3:RA3-RA3(2010).
RN   [15]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-461, AND IDENTIFICATION
RP   BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma, and Erythroleukemia;
RX   PubMed=23186163; DOI=10.1021/pr300630k;
RA   Zhou H., Di Palma S., Preisinger C., Peng M., Polat A.N., Heck A.J.,
RA   Mohammed S.;
RT   "Toward a comprehensive characterization of a human cancer cell
RT   phosphoproteome.";
RL   J. Proteome Res. 12:260-271(2013).
RN   [16]
RP   X-RAY CRYSTALLOGRAPHY (2.10 ANGSTROMS) IN COMPLEX WITH ADP AND
RP   FRUCTOSE 6-PHOSPHATE.
RX   PubMed=16316985; DOI=10.1074/jbc.M511019200;
RA   Kim S.G., Manes N.P., El-Maghrabi M.R., Lee Y.H.;
RT   "Crystal structure of the hypoxia-inducible form of 6-phosphofructo-2-
RT   kinase/fructose-2,6-bisphosphatase (PFKFB3): a possible new target for
RT   cancer therapy.";
RL   J. Biol. Chem. 281:2939-2944(2006).
RN   [17]
RP   X-RAY CRYSTALLOGRAPHY (2.25 ANGSTROMS) IN COMPLEXES WITH ADP; ATP;
RP   FRUCTOSE 6-PHOSPHATE; FRUCTOSE-2,6-BISPHOSPHATE AND
RP   PHOSPHOENOLPYRUVATE.
RX   PubMed=17499765; DOI=10.1016/j.jmb.2007.03.038;
RA   Kim S.G., Cavalier M., El-Maghrabi M.R., Lee Y.H.;
RT   "A direct substrate-substrate interaction found in the kinase domain
RT   of the bifunctional enzyme, 6-phosphofructo-2-kinase/fructose-2,6-
RT   bisphosphatase.";
RL   J. Mol. Biol. 370:14-26(2007).
RN   [18]
RP   X-RAY CRYSTALLOGRAPHY (2.25 ANGSTROMS), AND ACTIVE SITE.
RX   PubMed=22275052; DOI=10.1002/prot.24015;
RA   Cavalier M.C., Kim S.G., Neau D., Lee Y.H.;
RT   "Molecular basis of the fructose-2,6-bisphosphatase reaction of
RT   PFKFB3: transition state and the C-terminal function.";
RL   Proteins 80:1143-1153(2012).
RN   [19]
RP   X-RAY CRYSTALLOGRAPHY (2.03 ANGSTROMS) IN COMPLEX WITH
RP   FRUCTOSE-2,6-BISPHOSPHATE.
RX   PubMed=25849762; DOI=10.1021/acs.jmedchem.5b00352;
RA   Boyd S., Brookfield J.L., Critchlow S.E., Cumming I.A., Curtis N.J.,
RA   Debreczeni J., Degorce S.L., Donald C., Evans N.J., Groombridge S.,
RA   Hopcroft P., Jones N.P., Kettle J.G., Lamont S., Lewis H.J.,
RA   MacFaull P., McLoughlin S.B., Rigoreau L.J., Smith J.M., St-Gallay S.,
RA   Stock J.K., Turnbull A.P., Wheatley E.R., Winter J., Wingfield J.;
RT   "Structure-based design of potent and selective inhibitors of the
RT   metabolic kinase PFKFB3.";
RL   J. Med. Chem. 58:3611-3625(2015).
CC   -!- FUNCTION: Synthesis and degradation of fructose 2,6-bisphosphate.
CC   -!- CATALYTIC ACTIVITY: Beta-D-fructose 2,6-bisphosphate + H(2)O = D-
CC       fructose 6-phosphate + phosphate.
CC   -!- CATALYTIC ACTIVITY: ATP + D-fructose 6-phosphate = ADP + beta-D-
CC       fructose 2,6-bisphosphate.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=4;
CC       Name=1;
CC         IsoId=Q16875-1; Sequence=Displayed;
CC       Name=2;
CC         IsoId=Q16875-2; Sequence=VSP_004680;
CC       Name=3;
CC         IsoId=Q16875-3; Sequence=VSP_047165;
CC         Note=Gene prediction based on EST data.;
CC       Name=4;
CC         IsoId=Q16875-4; Sequence=VSP_054549;
CC         Note=No experimental confirmation available.;
CC   -!- TISSUE SPECIFICITY: Ubiquitous.
CC   -!- PTM: Phosphorylation by AMPK stimulates activity.
CC       {ECO:0000269|PubMed:12065600}.
CC   -!- SIMILARITY: In the C-terminal section; belongs to the
CC       phosphoglycerate mutase family. {ECO:0000305}.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; D49817; BAA08624.1; -; mRNA.
DR   EMBL; L77662; AAL40083.1; -; mRNA.
DR   EMBL; AF109735; AAD08818.1; -; mRNA.
DR   EMBL; AF041831; AAB99795.1; -; Genomic_DNA.
DR   EMBL; AF041823; AAB99795.1; JOINED; Genomic_DNA.
DR   EMBL; AF041824; AAB99795.1; JOINED; Genomic_DNA.
DR   EMBL; AF041825; AAB99795.1; JOINED; Genomic_DNA.
DR   EMBL; AF041826; AAB99795.1; JOINED; Genomic_DNA.
DR   EMBL; AF041827; AAB99795.1; JOINED; Genomic_DNA.
DR   EMBL; AF041828; AAB99795.1; JOINED; Genomic_DNA.
DR   EMBL; AF041829; AAB99795.1; JOINED; Genomic_DNA.
DR   EMBL; AF041830; AAB99795.1; JOINED; Genomic_DNA.
DR   EMBL; AF056320; AAC62000.1; -; mRNA.
DR   EMBL; AK291263; BAF83952.1; -; mRNA.
DR   EMBL; AK304450; BAH14191.1; -; mRNA.
DR   EMBL; AL359960; CAH72163.1; -; Genomic_DNA.
DR   EMBL; AL157395; CAH72163.1; JOINED; Genomic_DNA.
DR   EMBL; AL157395; CAH73606.1; -; Genomic_DNA.
DR   EMBL; AL359960; CAH73606.1; JOINED; Genomic_DNA.
DR   EMBL; CH471072; EAW86398.1; -; Genomic_DNA.
DR   EMBL; CH471072; EAW86399.1; -; Genomic_DNA.
DR   EMBL; BC040482; AAH40482.1; -; mRNA.
DR   CCDS; CCDS44353.1; -. [Q16875-3]
DR   CCDS; CCDS60479.1; -. [Q16875-4]
DR   CCDS; CCDS7078.1; -. [Q16875-1]
DR   CCDS; CCDS81439.1; -. [Q16875-2]
DR   PIR; JC4626; JC4626.
DR   RefSeq; NP_001269559.1; NM_001282630.2. [Q16875-4]
DR   RefSeq; NP_001300992.1; NM_001314063.1. [Q16875-2]
DR   RefSeq; NP_004557.1; NM_004566.3. [Q16875-1]
DR   UniGene; Hs.195471; -.
DR   PDB; 2AXN; X-ray; 2.10 A; A=1-520.
DR   PDB; 2DWO; X-ray; 2.25 A; A=1-520.
DR   PDB; 2DWP; X-ray; 2.70 A; A=1-520.
DR   PDB; 2I1V; X-ray; 2.50 A; B=1-520.
DR   PDB; 3QPU; X-ray; 2.30 A; A=1-520.
DR   PDB; 3QPV; X-ray; 2.50 A; A=1-520.
DR   PDB; 3QPW; X-ray; 2.25 A; A=1-520.
DR   PDB; 4D4J; X-ray; 3.00 A; A=1-449.
DR   PDB; 4D4K; X-ray; 3.24 A; A=1-449.
DR   PDB; 4D4L; X-ray; 3.16 A; A=1-449.
DR   PDB; 4D4M; X-ray; 2.32 A; A=1-449.
DR   PDB; 4MA4; X-ray; 2.23 A; A=1-520.
DR   PDB; 5AJV; X-ray; 3.01 A; B=1-520.
DR   PDB; 5AJW; X-ray; 2.50 A; A=1-520.
DR   PDB; 5AJX; X-ray; 2.58 A; A=1-520.
DR   PDB; 5AJY; X-ray; 2.37 A; A=1-520.
DR   PDB; 5AJZ; X-ray; 2.35 A; A=1-520.
DR   PDB; 5AK0; X-ray; 2.03 A; A=1-520.
DR   PDBsum; 2AXN; -.
DR   PDBsum; 2DWO; -.
DR   PDBsum; 2DWP; -.
DR   PDBsum; 2I1V; -.
DR   PDBsum; 3QPU; -.
DR   PDBsum; 3QPV; -.
DR   PDBsum; 3QPW; -.
DR   PDBsum; 4D4J; -.
DR   PDBsum; 4D4K; -.
DR   PDBsum; 4D4L; -.
DR   PDBsum; 4D4M; -.
DR   PDBsum; 4MA4; -.
DR   PDBsum; 5AJV; -.
DR   PDBsum; 5AJW; -.
DR   PDBsum; 5AJX; -.
DR   PDBsum; 5AJY; -.
DR   PDBsum; 5AJZ; -.
DR   PDBsum; 5AK0; -.
DR   ProteinModelPortal; Q16875; -.
DR   SMR; Q16875; -.
DR   BioGrid; 111230; 13.
DR   DIP; DIP-33964N; -.
DR   IntAct; Q16875; 6.
DR   STRING; 9606.ENSP00000369100; -.
DR   BindingDB; Q16875; -.
DR   ChEMBL; CHEMBL2331053; -.
DR   DEPOD; Q16875; -.
DR   iPTMnet; Q16875; -.
DR   PhosphoSitePlus; Q16875; -.
DR   BioMuta; PFKFB3; -.
DR   DMDM; 3023733; -.
DR   PaxDb; Q16875; -.
DR   PeptideAtlas; Q16875; -.
DR   PRIDE; Q16875; -.
DR   DNASU; 5209; -.
DR   Ensembl; ENST00000360521; ENSP00000353712; ENSG00000170525. [Q16875-2]
DR   Ensembl; ENST00000379775; ENSP00000369100; ENSG00000170525. [Q16875-1]
DR   Ensembl; ENST00000379789; ENSP00000369115; ENSG00000170525. [Q16875-3]
DR   Ensembl; ENST00000536985; ENSP00000443319; ENSG00000170525. [Q16875-4]
DR   GeneID; 5209; -.
DR   KEGG; hsa:5209; -.
DR   UCSC; uc001ijd.4; human. [Q16875-1]
DR   CTD; 5209; -.
DR   DisGeNET; 5209; -.
DR   GeneCards; PFKFB3; -.
DR   HGNC; HGNC:8874; PFKFB3.
DR   HPA; CAB020795; -.
DR   HPA; HPA008266; -.
DR   HPA; HPA043889; -.
DR   MIM; 605319; gene.
DR   neXtProt; NX_Q16875; -.
DR   OpenTargets; ENSG00000170525; -.
DR   PharmGKB; PA33213; -.
DR   eggNOG; KOG0234; Eukaryota.
DR   eggNOG; COG0406; LUCA.
DR   GeneTree; ENSGT00390000018751; -.
DR   HOGENOM; HOG000181112; -.
DR   HOVERGEN; HBG005628; -.
DR   InParanoid; Q16875; -.
DR   KO; K01103; -.
DR   OMA; ADEMPYL; -.
DR   OrthoDB; EOG091G0A43; -.
DR   PhylomeDB; Q16875; -.
DR   TreeFam; TF313541; -.
DR   BioCyc; MetaCyc:HS10144-MONOMER; -.
DR   BRENDA; 2.7.1.105; 2681.
DR   BRENDA; 3.1.3.46; 2681.
DR   Reactome; R-HSA-70171; Glycolysis.
DR   SABIO-RK; Q16875; -.
DR   SIGNOR; Q16875; -.
DR   ChiTaRS; PFKFB3; human.
DR   EvolutionaryTrace; Q16875; -.
DR   GeneWiki; PFKFB3; -.
DR   GenomeRNAi; 5209; -.
DR   PRO; PR:Q16875; -.
DR   Proteomes; UP000005640; Chromosome 10.
DR   Bgee; ENSG00000170525; -.
DR   CleanEx; HS_PFKFB3; -.
DR   ExpressionAtlas; Q16875; baseline and differential.
DR   Genevisible; Q16875; HS.
DR   GO; GO:0005829; C:cytosol; TAS:Reactome.
DR   GO; GO:0005654; C:nucleoplasm; IDA:HPA.
DR   GO; GO:0003873; F:6-phosphofructo-2-kinase activity; EXP:Reactome.
DR   GO; GO:0005524; F:ATP binding; IEA:UniProtKB-KW.
DR   GO; GO:0004331; F:fructose-2,6-bisphosphate 2-phosphatase activity; IEA:UniProtKB-EC.
DR   GO; GO:0007420; P:brain development; IEA:Ensembl.
DR   GO; GO:0061621; P:canonical glycolysis; TAS:Reactome.
DR   GO; GO:0006003; P:fructose 2,6-bisphosphate metabolic process; IEA:Ensembl.
DR   GO; GO:0006000; P:fructose metabolic process; IEA:InterPro.
DR   CDD; cd07067; HP_PGM_like; 1.
DR   Gene3D; 3.40.50.1240; -; 1.
DR   InterPro; IPR003094; 6Pfruct_kin.
DR   InterPro; IPR013079; 6Phosfructo_kin.
DR   InterPro; IPR013078; His_Pase_superF_clade-1.
DR   InterPro; IPR029033; His_PPase_superfam.
DR   InterPro; IPR027417; P-loop_NTPase.
DR   InterPro; IPR001345; PG/BPGM_mutase_AS.
DR   PANTHER; PTHR10606; PTHR10606; 1.
DR   Pfam; PF01591; 6PF2K; 1.
DR   Pfam; PF00300; His_Phos_1; 1.
DR   PRINTS; PR00991; 6PFRUCTKNASE.
DR   SMART; SM00855; PGAM; 1.
DR   SUPFAM; SSF52540; SSF52540; 1.
DR   SUPFAM; SSF53254; SSF53254; 1.
DR   PROSITE; PS00175; PG_MUTASE; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Alternative splicing; ATP-binding; Complete proteome;
KW   Hydrolase; Kinase; Multifunctional enzyme; Nucleotide-binding;
KW   Phosphoprotein; Reference proteome; Transferase.
FT   CHAIN         1    520       6-phosphofructo-2-kinase/fructose-2,6-
FT                                bisphosphatase 3.
FT                                /FTId=PRO_0000179968.
FT   NP_BIND      42     50       ATP. {ECO:0000269|PubMed:16316985,
FT                                ECO:0000269|PubMed:17499765,
FT                                ECO:0000269|PubMed:22275052}.
FT   NP_BIND     164    169       ATP. {ECO:0000269|PubMed:16316985,
FT                                ECO:0000269|PubMed:17499765,
FT                                ECO:0000269|PubMed:22275052}.
FT   NP_BIND     345    348       ATP. {ECO:0000250|UniProtKB:P07953}.
FT   NP_BIND     389    393       ATP. {ECO:0000250|UniProtKB:P07953}.
FT   REGION        1    245       6-phosphofructo-2-kinase.
FT   REGION      246    520       Fructose-2,6-bisphosphatase.
FT   ACT_SITE    125    125       {ECO:0000255}.
FT   ACT_SITE    155    155       {ECO:0000255}.
FT   ACT_SITE    254    254       Tele-phosphohistidine intermediate.
FT                                {ECO:0000269|PubMed:22275052}.
FT   ACT_SITE    323    323       Proton donor/acceptor.
FT                                {ECO:0000269|PubMed:22275052}.
FT   BINDING      75     75       Fructose 6-phosphate.
FT                                {ECO:0000269|PubMed:16316985}.
FT   BINDING      99     99       Fructose 6-phosphate.
FT                                {ECO:0000269|PubMed:16316985}.
FT   BINDING     127    127       Fructose 6-phosphate.
FT                                {ECO:0000269|PubMed:16316985}.
FT   BINDING     133    133       Fructose 6-phosphate.
FT                                {ECO:0000269|PubMed:16316985}.
FT   BINDING     169    169       Fructose 6-phosphate.
FT                                {ECO:0000269|PubMed:16316985}.
FT   BINDING     190    190       Fructose 6-phosphate.
FT                                {ECO:0000269|PubMed:16316985}.
FT   BINDING     194    194       Fructose 6-phosphate.
FT                                {ECO:0000269|PubMed:16316985}.
FT   BINDING     253    253       Fructose 2,6-bisphosphate.
FT                                {ECO:0000269|PubMed:25849762}.
FT   BINDING     260    260       Fructose 2,6-bisphosphate.
FT                                {ECO:0000269|PubMed:25849762}.
FT   BINDING     266    266       Fructose 2,6-bisphosphate; via amide
FT                                nitrogen. {ECO:0000269|PubMed:25849762}.
FT   BINDING     334    334       Fructose 2,6-bisphosphate.
FT                                {ECO:0000269|PubMed:25849762}.
FT   BINDING     348    348       Fructose 2,6-bisphosphate.
FT                                {ECO:0000269|PubMed:25849762}.
FT   BINDING     352    352       Fructose 2,6-bisphosphate.
FT                                {ECO:0000269|PubMed:25849762}.
FT   BINDING     363    363       Fructose 2,6-bisphosphate.
FT                                {ECO:0000269|PubMed:25849762}.
FT   BINDING     389    389       Fructose 2,6-bisphosphate.
FT                                {ECO:0000269|PubMed:25849762}.
FT   BINDING     393    393       Fructose 2,6-bisphosphate.
FT                                {ECO:0000250|UniProtKB:P07953}.
FT   BINDING     425    425       ATP. {ECO:0000269|PubMed:16316985,
FT                                ECO:0000269|PubMed:17499765,
FT                                ECO:0000269|PubMed:22275052}.
FT   SITE        253    253       Transition state stabilizer.
FT                                {ECO:0000269|PubMed:22275052}.
FT   SITE        260    260       Transition state stabilizer.
FT                                {ECO:0000269|PubMed:22275052}.
FT   SITE        388    388       Transition state stabilizer.
FT                                {ECO:0000269|PubMed:22275052}.
FT   MOD_RES     461    461       Phosphoserine; by AMPK.
FT                                {ECO:0000244|PubMed:18669648,
FT                                ECO:0000244|PubMed:19690332,
FT                                ECO:0000244|PubMed:20068231,
FT                                ECO:0000244|PubMed:23186163,
FT                                ECO:0000269|PubMed:12065600}.
FT   MOD_RES     463    463       Phosphothreonine.
FT                                {ECO:0000244|PubMed:18669648}.
FT   MOD_RES     467    467       Phosphoserine.
FT                                {ECO:0000244|PubMed:18669648,
FT                                ECO:0000244|PubMed:19690332,
FT                                ECO:0000244|PubMed:20068231}.
FT   MOD_RES     471    471       Phosphothreonine; by PKC. {ECO:0000250}.
FT   VAR_SEQ       1     26       MPLELTQSRVQKIWVPVDHRPSLPRS -> MPFRKA (in
FT                                isoform 3). {ECO:0000305}.
FT                                /FTId=VSP_047165.
FT   VAR_SEQ       1     26       MPLELTQSRVQKIWVPVDHRPSLPRS -> MGEGGQKEGDS
FT                                QQAGALPLLCQLDTFSPKATVFGVSINPA (in isoform
FT                                4). {ECO:0000303|PubMed:14702039}.
FT                                /FTId=VSP_054549.
FT   VAR_SEQ     506    520       NMKGSRSSADSSRKH -> PLLGQACLT (in isoform
FT                                2). {ECO:0000303|PubMed:10077634}.
FT                                /FTId=VSP_004680.
FT   CONFLICT    136    136       M -> V (in Ref. 4; AAB99795).
FT                                {ECO:0000305}.
FT   CONFLICT    141    141       A -> G (in Ref. 5; AAC62000).
FT                                {ECO:0000305}.
FT   STRAND        5      7       {ECO:0000244|PDB:5AK0}.
FT   TURN          9     11       {ECO:0000244|PDB:5AK0}.
FT   STRAND       14     16       {ECO:0000244|PDB:5AK0}.
FT   STRAND       36     43       {ECO:0000244|PDB:5AK0}.
FT   STRAND       44     47       {ECO:0000244|PDB:2DWP}.
FT   HELIX        48     61       {ECO:0000244|PDB:5AK0}.
FT   STRAND       66     70       {ECO:0000244|PDB:5AK0}.
FT   HELIX        71     78       {ECO:0000244|PDB:5AK0}.
FT   STRAND       79     81       {ECO:0000244|PDB:4D4M}.
FT   HELIX        85     88       {ECO:0000244|PDB:5AK0}.
FT   HELIX        93    116       {ECO:0000244|PDB:5AK0}.
FT   STRAND      120    126       {ECO:0000244|PDB:5AK0}.
FT   HELIX       131    144       {ECO:0000244|PDB:5AK0}.
FT   STRAND      147    154       {ECO:0000244|PDB:5AK0}.
FT   HELIX       157    163       {ECO:0000244|PDB:5AK0}.
FT   HELIX       165    169       {ECO:0000244|PDB:5AK0}.
FT   HELIX       173    175       {ECO:0000244|PDB:5AK0}.
FT   HELIX       180    195       {ECO:0000244|PDB:5AK0}.
FT   TURN        203    209       {ECO:0000244|PDB:5AK0}.
FT   STRAND      210    216       {ECO:0000244|PDB:5AK0}.
FT   TURN        217    220       {ECO:0000244|PDB:5AK0}.
FT   STRAND      221    225       {ECO:0000244|PDB:5AK0}.
FT   HELIX       230    241       {ECO:0000244|PDB:5AK0}.
FT   STRAND      249    253       {ECO:0000244|PDB:5AK0}.
FT   HELIX       258    261       {ECO:0000244|PDB:5AK0}.
FT   HELIX       273    289       {ECO:0000244|PDB:5AK0}.
FT   STRAND      295    298       {ECO:0000244|PDB:5AK0}.
FT   HELIX       302    309       {ECO:0000244|PDB:5AK0}.
FT   TURN        310    312       {ECO:0000244|PDB:5AK0}.
FT   STRAND      315    317       {ECO:0000244|PDB:2AXN}.
FT   HELIX       319    321       {ECO:0000244|PDB:5AK0}.
FT   HELIX       327    329       {ECO:0000244|PDB:5AK0}.
FT   HELIX       334    340       {ECO:0000244|PDB:5AK0}.
FT   HELIX       342    350       {ECO:0000244|PDB:5AK0}.
FT   TURN        352    354       {ECO:0000244|PDB:5AK0}.
FT   HELIX       363    379       {ECO:0000244|PDB:5AK0}.
FT   STRAND      381    387       {ECO:0000244|PDB:5AK0}.
FT   HELIX       389    399       {ECO:0000244|PDB:5AK0}.
FT   TURN        404    406       {ECO:0000244|PDB:5AK0}.
FT   HELIX       407    409       {ECO:0000244|PDB:5AK0}.
FT   STRAND      416    423       {ECO:0000244|PDB:5AK0}.
FT   STRAND      426    433       {ECO:0000244|PDB:5AK0}.
FT   HELIX       442    446       {ECO:0000244|PDB:3QPU}.
FT   HELIX       455    457       {ECO:0000244|PDB:2AXN}.
SQ   SEQUENCE   520 AA;  59609 MW;  A7675A4ADC376879 CRC64;
     MPLELTQSRV QKIWVPVDHR PSLPRSCGPK LTNSPTVIVM VGLPARGKTY ISKKLTRYLN
     WIGVPTKVFN VGEYRREAVK QYSSYNFFRP DNEEAMKVRK QCALAALRDV KSYLAKEGGQ
     IAVFDATNTT RERRHMILHF AKENDFKAFF IESVCDDPTV VASNIMEVKI SSPDYKDCNS
     AEAMDDFMKR ISCYEASYQP LDPDKCDRDL SLIKVIDVGR RFLVNRVQDH IQSRIVYYLM
     NIHVQPRTIY LCRHGENEHN LQGRIGGDSG LSSRGKKFAS ALSKFVEEQN LKDLRVWTSQ
     LKSTIQTAEA LRLPYEQWKA LNEIDAGVCE ELTYEEIRDT YPEEYALREQ DKYYYRYPTG
     ESYQDLVQRL EPVIMELERQ ENVLVICHQA VLRCLLAYFL DKSAEEMPYL KCPLHTVLKL
     TPVAYGCRVE SIYLNVESVC THRERSEDAK KGPNPLMRRN SVTPLASPEP TKKPRINSFE
     EHVASTSAAL PSCLPPEVPT QLPGQNMKGS RSSADSSRKH
//
